CLINICAL STUDY ON I. V. DRIP INFUSION OF HBK IN THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS

HBK, a new aminoglycoside, was administered as 1 hr drip infusions intravenously to determine its utility in the treatment of complicated urinary tract infections with following results. 1) In 18 cases of complicated urinary tract infections, HBK was administered at dosages of 75 to 100mg twice a da...

Full description

Saved in:

Bibliographic Details
Published in:	CHEMOTHERAPY Vol. 34; no. Supplement1; pp. 459 - 464
Main Authors:	ITANI, ATSUSHI, FUJII, AKIRA, NAKANISHI, TAKEO, KAWAHATA, GAKU, ARAKAWA, SOICHI, KATAOKA, NOBUMASA, KAMIDONO, SADAO, ISHIGAMI, JOJI
Format:	Journal Article
Language:	English Japanese
Published:	Japanese Society of Chemotherapy 1986
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	HBK, a new aminoglycoside, was administered as 1 hr drip infusions intravenously to determine its utility in the treatment of complicated urinary tract infections with following results. 1) In 18 cases of complicated urinary tract infections, HBK was administered at dosages of 75 to 100mg twice a day for a period of 5 days and results were assessed according to the criteria for evaluation of drug efficacy for UTI. As to clinical results, an efficacy rate of 27.8% was obtained, while bacteriologically an eradication rate of 63.6%(14/22) was recorded. 2) In none of the cases any adverse reactions were observed either subjectively or objectively, nor any laboratory abnormalities were noted.
ISSN:	0009-3165 1884-5894
DOI:	10.11250/chemotherapy1953.34.Supplement1_459